Showing results (161-170 of 266) with videos related to
Sort By:
Pageof 27
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1996
Acute and anticipatory emesis in breast cancer patientsA Fernández-Marcos, M Martín, J J Sanchez, et al.American Journal of Clinical Oncology|February 24, 2001
Methotrexate, uracil and tegafur, and leucovorin chemotherapy for patients with breast cancer in progression after high-dose chemotherapy with peripheral blood progenitor cell transplant: a phase II studyM Martín, A Casado, J A Macias, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide in advanced epidermoid head and neck cancerM Martín, E Diaz-Rubio, J L González Larriba, et al.Cytotherapy|July 9, 2008
Cryopreserved human bone marrow mononuclear cells as a source of mesenchymal stromal cells: application in osteoporosis researchA Casado-Díaz, R Santiago-Mora, R Jiménez, et al.Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Bevacizumab in combination with metronomic chemotherapy in patients with anthracycline- and taxane-refractory breast cancerJ A García-Sáenz, M Martín, A Calles, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 2, 2016
SEOM Clinical Guideline in ovarian cancer (2016)A Santaballa, P Barretina, A Casado, et al.Breast Cancer Research and Treatment|November 20, 1998
Weekly continuous infusion of 5-fluorouracil with oral leucovorin in metastatic breast cancer patients with primary resistance to doxorubicinY Nieto, M Martín, J L Alonso, et al.Surgical Endoscopy|April 25, 2020
Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysisL Rodríguez-Ortiz, A Arjona-Sánchez, M Ibañez-Rubio, et al.Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 20, 2008
[Psychometric characteristics of the antiretroviral treatment satisfaction scale (ESTAR): ARPAS study (I)]J M Ventura Cerdá, M A Casado Gómez, J M Morales González, et al.European Journal of Cancer (Oxford, England : 1990)|July 20, 2014
A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgeryI Vergote, A Oaknin, J-F Baurain, et al.Pageof 27